Severe Hemolytic Anaemia due to Pyruvate Kinase Deficiency in a Patient With Coexistent β‐Thalassaemia Trait: A Case Report

Tugba Belgemen‐Ozer

doi:10.1111/jpc.70174

August 15, 2025Journal of Paediatrics and Child Health

Severe Hemolytic Anaemia due to Pyruvate Kinase Deficiency in a Patient With Coexistent β‐Thalassaemia Trait: A Case Report

View at Publisher

Ask AI

Bookmark

Share

Key Points

Severe hemolytic anaemia was identified as a complication due to pyruvate kinase deficiency in the patient.
The patient also presented with β-thalassaemia trait, complicating the clinical picture significantly.
Appropriate management strategies are critical for patients with both pyruvate kinase deficiency and β-thalassaemia.
Further investigation is needed to understand the full impact of these combined conditions.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Case report reveals severe hemolytic anaemia due to pyruvate kinase deficiency in a patient with β-thalassaemia, indicating potential treatment challenges.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tugba Belgemen‐Ozer (2025) studied this question.

synapsesocial.com/papers/68c1c64554b1d3bfb60f2884 https://doi.org/10.1111/jpc.70174

View at Publisher

Ask AI

Bookmark

Share

Severe Hemolytic Anaemia due to Pyruvate Kinase Deficiency in a Patient With Coexistent β‐Thalassaemia Trait: A Case Report

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Severe Hemolytic Anaemia due to Pyruvate Kinase Deficiency in a Patient With Coexistent β‐Thalassaemia Trait: A Case Report

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading